These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 33973373

  • 21. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open-label, crossover trial.
    Kwan TH, Lui GCY, Lam TTN, Lee KCK, Wong NS, Chan DPC, Lee SS.
    J Int AIDS Soc; 2021 Sep; 24(9):e25795. PubMed ID: 34473402
    [Abstract] [Full Text] [Related]

  • 22. Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    Zimmermann HML, Jongen VW, Boyd A, Hoornenborg E, Prins M, de Vries HJC, Schim van der Loeff MF, Davidovich U, Amsterdam PrEP Project Team in the HIV Transmission Elimination Amsterdam Initiative (H-TEAM).
    AIDS; 2020 Dec 01; 34(15):2295-2304. PubMed ID: 33196494
    [Abstract] [Full Text] [Related]

  • 23. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H, Zhang Y, Mei Z, Jia Y, Leuba SI, Zhang J, Chu Z, Ding H, Jiang Y, Geng W, Shang H, Xu J.
    BMC Infect Dis; 2019 Aug 15; 19(1):721. PubMed ID: 31416439
    [Abstract] [Full Text] [Related]

  • 24. A Mobile Application to Collect Daily Data on Preexposure Prophylaxis Adherence and Sexual Behavior Among Men Who Have Sex With Men: Use Over Time and Comparability With Conventional Data Collection.
    Finkenflügel RNN, Hoornenborg E, Achterbergh RCA, Marra E, Davidovich U, de Vries HJC, Prins M, Schim van der Loeff MF, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM).
    Sex Transm Dis; 2019 Jun 15; 46(6):400-406. PubMed ID: 30882717
    [Abstract] [Full Text] [Related]

  • 25. Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile application.
    van den Elshout MAM, Hoornenborg E, Achterbergh RCA, Coyer L, Anderson PL, Davidovich U, de Vries HJC, Prins M, van der Loeff MFS, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM).
    AIDS; 2021 Sep 01; 35(11):1823-1834. PubMed ID: 34001705
    [Abstract] [Full Text] [Related]

  • 26. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM, Stall RD, Rebe K, Egan JE, De Swardt G, Struthers H, McIntyre JA.
    AIDS Behav; 2016 Dec 01; 20(Suppl 3):357-364. PubMed ID: 27631366
    [Abstract] [Full Text] [Related]

  • 27. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM.
    JAMA Pediatr; 2017 Nov 01; 171(11):1063-1071. PubMed ID: 28873128
    [Abstract] [Full Text] [Related]

  • 28. The ATEAM study: Advances in technology to enhance PrEP adherence monitoring (ATEAM) among young men who have sex with men.
    Brothers J, Hosek S, Keckler K, Anderson PL, Xiong D, Liu H, Huhn G.
    Clin Transl Sci; 2022 Dec 01; 15(12):2947-2957. PubMed ID: 36106611
    [Abstract] [Full Text] [Related]

  • 29. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, ANRS IPERGAY Study Group.
    AIDS Care; 2016 Dec 01; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [Abstract] [Full Text] [Related]

  • 30. Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.
    Blumenthal J, Moore DJ, Jain S, Sun X, Ellorin E, Corado K, Hoenigl M, Dube M, Haubrich R, Morris SR.
    AIDS Patient Care STDS; 2019 May 01; 33(5):220-226. PubMed ID: 31067122
    [Abstract] [Full Text] [Related]

  • 31. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
    Coyer L, Prins M, Davidovich U, van Bilsen WPH, Schim van der Loeff MF, Hoornenborg E, Matser A, Boyd A.
    AIDS Patient Care STDS; 2022 Jun 01; 36(6):208-218. PubMed ID: 35687814
    [Abstract] [Full Text] [Related]

  • 32. Pre-exposure prophylaxis in real life: experience from a prospective, observational and demonstration project among men who have sex with men in Benin, West Africa.
    Diabaté S, Béhanzin L, Guédou FA, Goma-Matsétsé E, Olodo M, Aza-Gnandji M, Dossouvo A, Akpaka A, Chagas E, Gangbo F, Zannou DM, Alary M.
    J Int AIDS Soc; 2023 Jun 01; 26(6):e26130. PubMed ID: 37306106
    [Abstract] [Full Text] [Related]

  • 33. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM, ANRS IPERGAY study group.
    Lancet HIV; 2020 Feb 01; 7(2):e113-e120. PubMed ID: 31784343
    [Abstract] [Full Text] [Related]

  • 34. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.
    Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M.
    Clin Infect Dis; 2018 Jan 06; 66(2):213-219. PubMed ID: 29020194
    [Abstract] [Full Text] [Related]

  • 35. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    Tapsoba JD, Cover J, Obong'o C, Brady M, Cressey TR, Mori K, Okomo G, Kariithi E, Obanda R, Oluoch-Madiang D, Chen YQ, Drain P, Duerr A.
    PLoS Med; 2022 Sep 06; 19(9):e1004097. PubMed ID: 36095005
    [Abstract] [Full Text] [Related]

  • 36. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, Katlama C, Slama L, Liegeon G, Beniguel L, Ohayon M, Mouhim H, Goldwirt L, Spire B, Loze B, Surgers L, Pavie J, Lourenco J, Ben-Mechlia M, Le Mestre S, Rojas-Castro D, Costagliola D, ANRS PREVENIR Study Group.
    Lancet HIV; 2022 Aug 06; 9(8):e554-e562. PubMed ID: 35772417
    [Abstract] [Full Text] [Related]

  • 37. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men.
    Shieh E, Marzinke MA, Fuchs EJ, Hamlin A, Bakshi R, Aung W, Breakey J, Poteat T, Brown T, Bumpus NN, Hendrix CW.
    J Int AIDS Soc; 2019 Nov 06; 22(11):e25405. PubMed ID: 31692269
    [Abstract] [Full Text] [Related]

  • 38. Adherence to Daily Oral TDF/FTC for PrEP in Community Health Center Populations: The Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study.
    Smith DK, Rawlings MK, Glick N, Mena L, Coleman M, Houlberg M, McCallister S, Wiener J.
    AIDS Behav; 2022 Feb 06; 26(2):350-360. PubMed ID: 34347198
    [Abstract] [Full Text] [Related]

  • 39. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
    Laurent C, Dembélé Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traoré I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Fayé-Ketté H, Koné A, Diandé S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B, CohMSM-PrEP Study Group.
    Lancet HIV; 2021 Jul 06; 8(7):e420-e428. PubMed ID: 34048794
    [Abstract] [Full Text] [Related]

  • 40. Effect of HIV Self-Testing on PrEP Adherence Among Gender-Diverse Sex Workers in Uganda: A Randomized Trial.
    Mujugira A, Nakyanzi A, Nabaggala MS, Muwonge TR, Ssebuliba T, Bagaya M, Nampewo O, Sapiri O, Nyanzi KR, Bambia F, Nsubuga R, Serwadda DM, Ware NC, Baeten JM, Haberer JE.
    J Acquir Immune Defic Syndr; 2022 Apr 01; 89(4):381-389. PubMed ID: 34954718
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.